dr. roy herbst over de opkomst van immunotherapie bij kanker
Published 11 years ago • 1.1K plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
1:56
dr. herbst over de vooruitgang van immunotherapie bij longkanker
-
1:49
dr. herbst over de impact van eerstelijnsimmunotherapie bij longkanker
-
1:03
dr. herbst on combination therapies for lung cancer
-
0:58
dr. herbst on immunotherapy in lung cancer
-
1:22
dr. herbst on immune resistance in lung cancer
-
10:30
new hope for advanced thyroid cancer patients
-
26:13
immunotherapies in lung cancer | 2022 evolution conference
-
6:39
latest developments in oral cancer treatment: pdl-1 inhibitors
-
0:47
dr. roy herbst on selecting patients for molecular testing in nsclc
-
1:35
dr. herbst on immuno-oncology combinations in lung cancer
-
1:06
dr. herbst on the unique benefit of targeting the pd-1/pd-l1 pathway in lung cancer
-
1:00
dr. herbst discusses immunotherapy in lung cancer
-
2:41
dr. roy herbst describes the efficacy of immune checkpoint inhibitors
-
1:23
dr. roy s. herbst explores molecular testing in lung cancer
-
1:13
dr. herbst on targeting pd-1 and pd-l1 in lung cancer
-
1:18
dr. herbst on next-generation agents in nsclc
-
1:31
roy herbst, md, phd, explains the 3-year length of adjuvant treatment strategy in adaura
-
1:20
dr. herbst discusses new immunotherapy agents for lung cancer
-
1:03
dr. roy herbst on antibodies used against egfr alongside chemotherapy
-
2:15
dr. herbst on the next generation of lung cancer trials
-
1:18
immunotherapie bij huidkanker - prof. figdor
-
4:15
an overview of immunotherapy in thoracic cancer by roy herbst
-
1:26
dr. herbst on mpdl3280a for non-small cell lung cancer
-
1:02
dr. herbst on pd-1 inhibitors in lung cancer
-
2:29
dr. herbst discusses the state of immunotherapy in lung cancer